title: Hepatorenal syndrome: outcome of response to therapy and predictors of survival.
abstract: Aim. Treatment of hepatorenal syndrome (HRS) in patients with liver cirrhosis is still challenging and characterized by a very high mortality. This study aimed to delineate treatment patterns and clinical outcomes of patients with HRS intravenously treated with terlipressin. Methods. In this retrospective single-center cohort study, 119 patients (median [IQR]; 56.50 [50.75-63.00] years of age) with HRS were included. All patients were treated with terlipressin and human albumin intravenously. Those with response to treatment (n = 65) were compared to the patient cohort without improvement (n = 54). Patient characteristics and clinical parameters (Child stage, ascites, hepatic encephalopathy, HRS type I/II, and initial MELD score) were retrieved. Univariate analysis of factors influencing the success of terlipressin therapy and Cox regression analysis of factors influencing survival was carried out. Results. One-month survival was significantly longer in the group of responders (p = 0.048). Cox regression analysis identified age [Hazard ratio, 95% confidence interval (CI); 1.05, 1.01-1.09, resp.], alcohol abuse [HR 3.05, 95% CI 1.11-8.38], duration of treatment [HR 0.92, 95% CI 0.88-0.96], and MELD score [HR 1.08, 95% CI 1.02-1.14] to be independent predictors of survival. Conclusions. Survival of HRS patients after treatment depends on age, etiology of liver disease, and the duration of treatment.
authors.affiliation: Department of Gastroenterology, Klinikum Bielefeld, 33604 Bielefeld, Germany.
authors.forename: Jan
authors.initials: J
authors.lastname: Heidemann
authors.affiliation: Department of Medicine B, University of Münster, 48149 Münster, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Bartels
authors.affiliation: Department of Medicine B, University of Münster, 48149 Münster, Germany.
authors.forename: Christoph
authors.initials: C
authors.lastname: Berssenbrügge
authors.affiliation: Department of Transplantation Medicine, University of Münster, 48149 Münster, Germany.
authors.forename: Hartmut
authors.initials: H
authors.lastname: Schmidt
authors.affiliation: Department of Medicine II, HELIOS Albert-Schweitzer Hospital, Academic Teaching Hospital of Georg-August-University of Göttingen, 37154 Northeim, Germany.
authors.forename: Tobias
authors.initials: T
authors.lastname: Meister